title: [Is there a special indication for fluphenazine in therapy refractory hallucinations?].
abstract: On one of our rehabilitation wards, we observed several schizophrenic patients with therapy resistant hallucinations to exhibit complete recovery after being given fluphenazine (2-7.5 mg a day, orally); previously, they were found to be therapy resistant on other potent neuroleptics, including clozapine. It appears that in selected patients fluphenazine has a special antihallucinatory effect.
authors: Abteilung Psychiatrie II, Universität Ulm.
authors: K
authors: K
authors: Bechter
mesh_terms: D003024:Clozapine / Q000627:therapeutic use; D003702:Delusions / Q000188:drug therapy / Q000523:psychology; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005476:Fluphenazine / Q000627:therapeutic use*; D006212:Hallucinations / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D012559:Schizophrenia / Q000188:drug therapy*; D012563:Schizophrenia, Paranoid / Q000188:drug therapy / Q000523:psychology; D012565:Schizophrenic Psychology
chemical_list: D003024:Clozapine; D005476:Fluphenazine
vernacular_title: Gibt es eine spezielle Indikation für Fluphenazin bei therapieresistenten Halluzinationen?